Twist Bioscience (TWST) Change in Receivables (2017 - 2026)
Twist Bioscience has reported Change in Receivables over the past 10 years, most recently at $14.2 million for Q1 2026.
- Quarterly Change in Receivables rose 32.79% to $14.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $14.5 million through Mar 2026, up 2.24% year-over-year, with the annual reading at $22.4 million for FY2025, 365.06% up from the prior year.
- Change in Receivables was $14.2 million for Q1 2026 at Twist Bioscience, up from -$6.8 million in the prior quarter.
- Over five years, Change in Receivables peaked at $14.2 million in Q1 2026 and troughed at -$8.1 million in Q4 2023.
- The 5-year median for Change in Receivables is $1.8 million (2022), against an average of $2.0 million.
- Year-over-year, Change in Receivables crashed 328.28% in 2022 and then skyrocketed 1531.96% in 2025.
- A 5-year view of Change in Receivables shows it stood at $4.1 million in 2022, then plummeted by 296.63% to -$8.1 million in 2023, then skyrocketed by 156.3% to $4.5 million in 2024, then tumbled by 250.45% to -$6.8 million in 2025, then soared by 308.58% to $14.2 million in 2026.
- Per Business Quant, the three most recent readings for TWST's Change in Receivables are $14.2 million (Q1 2026), -$6.8 million (Q4 2025), and $7.2 million (Q3 2025).